Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
CEFIXIME TRIHYDRATE
Amdipharm Limited
J01DD; J01DD08
CEFIXIME TRIHYDRATE
Film-coated tablet
Third-generation cephalosporins; cefixime
Marketed
1989-01-05
PACKAGE LEAFLET: INFORMATION FOR THE USER SUPRAX 200MG FILM-COATED TABLETS Cefixime IS THIS LEAFLET HARD TO SEE OR READ? PHONE +353 1800 851 119 FOR HELP READ ALL OF THIS LEAFLET CAREFULLY BEFORE TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or your pharmacist. • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Suprax is and what it is used for 2. What you need to know before you take Suprax 3. How to take Suprax 4. Possible side effects 5. How to store Suprax 6. Contents of the pack and other information 1. WHAT SUPRAX IS AND WHAT IT IS USED FOR Suprax 200mg Tablets (called Suprax in this leaflet) contains a medicine called cefixime. This belongs to a group of antibiotics called ‘cephalosporins’. Suprax is used to treat infections caused by bacteria. These include treating infections in the upper respiratory tract and also in the urinary tract. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE SUPRAX DO NOT TAKE THIS MEDICINE AND TELL YOUR DOCTOR IF : You are allergic (hypersensitive) to cefixime, any other cephalosporin antibiotics including penicillin or to any of the other ingredients of this medicine (listed in Section 6). Signs of an allergic reaction include: a rash, swallowing or breathing problems, swelling of the lips, face, throat and tongue. Do not take this medicine if the above applies to you. If you are not sure, talk to your doctor or your pharmacist before taking Suprax. WARNINGS AND PRECAUTIONS TALK TO YOUR DOCTOR OR PHARMACIST BEFORE TAKING SUPRAX IF: ▲ You have ever had colitis ▲ You have allergic tendencies such as asthma, rash or hives ▲ You have kidney problems ▲ The person taking this me Read the complete document
Health Products Regulatory Authority 18 August 2023 CRN00DJWP Page 1 of 7 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Suprax 200 mg Film-coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains Cefixime Trihydrate equivalent to cefixime 200 mg. For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Film-coated tablet Off-white to cream, circular, convex, embossed ‘ORO’ on one face. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For use in the treatment of infections due to micro-organisms sensitive to the antibiotic including pathogens such as _Streptococci pneumoniae_ and _pyogenes_, _E.coli_, Proteus, _H. influenza_ and_ B. catarrhalis_ (both beta lactamase positive and negative), Klebsiella and Enterobacter species. Most Enterococci, Staphylococci, Pseudomonas, Clostridia, _Bacteroides fragilis_ and_ Listeria monoyctogenes_ are resistant to Cefixime. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Route of administration is oral. ADULTS AND CHILDREN OF 12 YEARS AND OVER (OR MORE THAN 50KG BODY WEIGHT): The usual daily dose is 200-400mg in single or twice daily dosage regimen. In uncomplicated upper respiratory tract infections or urinary tract infections a daily dose of 200 mg may be sufficient. CHILDREN AGED 9 TO 12 YEARS: The usual total daily dose is 300mg (15ml of oral suspension) in single or twice daily regimen. CHILDREN AGED 5 TO 8 YEARS: The usual total daily dose is 200 mg (10ml of oral suspension) in single or twice daily dosage regimen. CHILDREN AGED 2 TO 4 YEARS: The usual total daily dose is 100 mg (5ml of oral suspension) in single or twice daily dosage regimen. CHILDREN AGED 6 MONTHS TO 2 YEARS: The usual total daily dose in 8 mg/kg in single or twice daily regimen. The safety and efficacy of use in infants less than 6 months of age has not been established. ELDERLY: The usual dosage is as for adults with appropriate modifications on the basis of renal impairment. PATIENTS WITH RENAL IMPAIRMENT Dosage does not require modification in p Read the complete document